| NORDEA 2 - BETAPLUS ENHANCED EMERGING MARKETS SUSTAINABLE EQUITY FUND BI2-EUR | RVI EMERGENTES | 44,54% | · | · | · |
| SCHRODER ISF JAPANESE EQUITY I ACC EUR (HEDGED) | RVI JAPÓN | 44,54% | 87,16% | 112,07% | 249,95% |
| CANDRIAM EQUITIES L ROBOTICS & INNOVATIVE TECHNOLOGY R-H CAP EUR | RVI TECNOLOGÍA | 44,53% | 84,80% | 68,25% | · |
| FIDELITY FUNDS-ASIA EQUITY ESG Y-DIST-EUR | RVI ASIA EX-JAPÓN | 44,52% | 50,10% | 26,74% | 136,99% |
| COMGEST GROWTH ASIA EUR I ACC | RVI ASIA PACÍFICO | 44,50% | 50,95% | 15,45% | 112,74% |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO R (SNAP) USD CAP | RVI USA SMALL/MID CAP | 44,50% | 74,37% | 74,11% | 206,65% |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 44,50% | 18,65% | -22,73% | · |
| ALGER SICAV - ALGER EMERGING MARKETS FUND A USD | RVI EMERGENTES | 44,49% | 56,52% | 7,51% | · |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO R (CLOSE) GBP DIS | RVI EMERGENTES | 44,49% | 64,07% | 30,17% | 103,33% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 44,49% | 17,30% | -24,42% | · |
